This site is intended for health professionals only

Published on 15 August 2011

Share this story:

RELATED ARTICLES
Opportunities and challenges in cardiovascular treatment: insights from the ESC president
Targeted treatments for childhood febrile illnesses possible with new immune cell insights
Study supports mineralocorticoid receptor antagonist use in all patients with heart failure
Research digest: regulation for small-scale preparation of unlicensed radiopharmaceuticals
Implementing shared care agreements for amiodarone therapy: a pharmacy case study

UKCPA release statement on stroke anticoagulants

teaser



Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
FDA approves “heavy period” drug
Innovative therapies receive Japanese approval
Safety fears around US diet pill
Avelumab approved by SMC as maintenance therapy for urothelial cancer
Using pharmacogenomics to improve medicines use after myocardial infarction
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x